THC Biomed Intl Ltd.

THC

CA87243W1032

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 12:55:44 2024-01-31 pm EST			5-day change	1st Jan Change
0.02 ^CAD	-.--%		-.--%	-.--%

2023	THC Biomed Intl Ltd. Introduces Always Hi New Brand Catering to Maturing Cannabis Consumer Trends	CI
2023	Thc Biomed Intl Ltd. Launches New Summer Cannabis Product: Thc Kiss Strawberry Tangerine Gummies	CI

THC BioMed Announces Shipment of Kiss Mango Beverage Shot to Ontario Cannabis Stores

August 17, 2021 at 08:00 am EDT

THC BioMed Intl Ltd. announced that it has completed a shipment of its THC Kiss Mango Beverage shot to Ontario Cannabis Stores.

Latest news about THC Biomed Intl Ltd.

THC Biomed Intl Ltd. Introduces Always Hi New Brand Catering to Maturing Cannabis Consumer Trends	Dec. 08	CI
Thc Biomed Intl Ltd. Launches New Summer Cannabis Product: Thc Kiss Strawberry Tangerine Gummies	23-07-04	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-29	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-04-03	CI
THC Biomed Intl Ltd. acquired 40% stake in THC BioMed Co. Ltd for $0.06 million.	23-04-02	CI
THC Biomed Intl Ltd. to Open First Medical Cannabis Dispensary in Asia	23-02-24	CI
THC Biomed Intl Ltd. Announces CBD KISS Mango Beverage Shot and CBD Biscuits Begin sales in Ontario	23-02-24	CI
THC Biomed Intl Ltd. Reports Earnings Results for the First Quarter Ended October 31, 2022	22-12-29	CI
THC Biomed Intl Ltd. Auditor Raises 'Going Concern' Doubt	22-11-23	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Full Year Ended July 31, 2022	22-11-23	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	22-06-29	CI
THC Biomed Intl Ltd. Announces Broker and Commercial Sales Agreement with World Wide Brands Limited	22-06-13	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	22-04-01	CI
THC BioMed Intl Ltd. Announces Availability of THC KISS Cannabis Biscuits to Consumers Through Ontario Cannabis Store Online and Wholesale to Ontario Retail Stores	22-02-02	CI
THC Biomed Intl Ltd. Grants Licence by Overseas Government to Cultivate Cannabis for Medical and Scientific Use	22-01-27	CI
THC Biomed Intl Ltd. announced that it has received CAD 0.25 million in funding	22-01-06	CI
THC Biomed Intl Ltd. Reports Earnings Results for the First Quarter Ended October 31, 2021	21-11-29	CI
THC Biomed Intl Ltd. Auditor Raises 'Going Concern' Doubt	21-11-28	CI
THC Biomed Intl Ltd. Reports Earnings Results for the Full Year Ended July 31, 2021	21-11-28	CI
THC BioMed Intl Ltd. Announces Three New Products to be List and Sold through Ontario Cannabis Stores	21-09-24	CI
THC Biomed Intl Ltd. Receives Purchase Orders from 30 Dispensaries in the Province of Manitoba	21-09-23	CI
THC KISS Mango Beverage Shot Ships to BC Cannabis Stores	21-09-01	CI
THC BioMed Announces Shipment of THC KISS Cannabis Biscuits to BC Cannabis Stores	21-08-31	CI
THC BioMed Announces 2nd Shipment of THC KISS Cannabis Biscuits to Saskatchewan	21-08-26	CI
THC BioMed Announces Shipment of Kiss Mango Beverage Shot to Ontario Cannabis Stores	21-08-17	CI

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).

Sector

Pharmaceuticals

Calendar

2024-06-26 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
THC BIOMED INTL LTD.	-.--%	2.4M
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.13%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-9.75%	3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+2.14%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.82%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.87%	1.97B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.09%	1.65B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.97%	1.53B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.40%	1.38B

Alternative Medicine

THC Biomed Intl Ltd.

Equities

THC

CA87243W1032

Pharmaceuticals

THC BioMed Announces Shipment of Kiss Mango Beverage Shot to Ontario Cannabis Stores

Latest news about THC Biomed Intl Ltd.

Chart THC Biomed Intl Ltd.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Alternative Medicine